Dr. Peter Ventre, MD

Claim this profile

Research Centers of America

Studies Depression, Bipolar Disorder
Studies Depression
3 reported clinical trials
5 drugs studied

Affiliated Hospitals

Image of trial facility.
Research Centers Of America

More about Peter Ventre, MD

Clinical Trial Related5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Peter Ventre, MD has experience with
  • Placebo
  • SEP-363856
  • NRX100
  • NRX-101
  • Lurasidone HCl

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Ventre, MD specialize in?
Peter Ventre, MD focuses on Depression, Bipolar Disorder and Depression. In particular, much of their work with Depression, Bipolar Disorder has involved treating patients, or patients who are undergoing treatment.
Is Peter Ventre, MD currently recruiting for clinical trials?
No, Peter Ventre, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Peter Ventre, MD has studied deeply?
Yes, Peter Ventre, MD has studied treatments such as Placebo, SEP-363856, NRX100.
What is the best way to schedule an appointment with Peter Ventre, MD?
Apply for one of the trials that Peter Ventre, MD is conducting.
What is the office address of Peter Ventre, MD?
The office of Peter Ventre, MD is located at: Research Centers of America, Hollywood, Florida 33024 United States. This is the address for their practice at the Research Centers of America.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.